These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16361594)

  • 1. Amantadine for treatment of fatigue in Guillain-Barre syndrome: a randomised, double blind, placebo controlled, crossover trial.
    Garssen MP; Schmitz PI; Merkies IS; Jacobs BC; van der Meché FG; van Doorn PA
    J Neurol Neurosurg Psychiatry; 2006 Jan; 77(1):61-5. PubMed ID: 16361594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatigue, Pain, Anxiety and Depression in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    Merkies IS; Kieseier BC
    Eur Neurol; 2016; 75(3-4):199-206. PubMed ID: 27077919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial.
    Tomassini V; Pozzilli C; Onesti E; Pasqualetti P; Marinelli F; Pisani A; Fieschi C
    J Neurol Sci; 2004 Mar; 218(1-2):103-8. PubMed ID: 14759641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amantadine for fatigue in multiple sclerosis.
    Taus C; Giuliani G; Pucci E; D'Amico R; Solari A
    Cochrane Database Syst Rev; 2003; (2):CD002818. PubMed ID: 12804439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial.
    Nourbakhsh B; Revirajan N; Morris B; Cordano C; Creasman J; Manguinao M; Krysko K; Rutatangwa A; Auvray C; Aljarallah S; Jin C; Mowry E; McCulloch C; Waubant E
    Lancet Neurol; 2021 Jan; 20(1):38-48. PubMed ID: 33242419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical training and fatigue, fitness, and quality of life in Guillain-Barré syndrome and CIDP.
    Garssen MP; Bussmann JB; Schmitz PI; Zandbergen A; Welter TG; Merkies IS; Stam HJ; van Doorn PA
    Neurology; 2004 Dec; 63(12):2393-5. PubMed ID: 15623709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amantadine for fatigue in multiple sclerosis.
    Pucci E; Branãs P; D'Amico R; Giuliani G; Solari A; Taus C
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD002818. PubMed ID: 17253480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual fatigue is independent of antecedent events and disease severity in Guillain-Barré syndrome.
    Garssen MP; Van Koningsveld R; Van Doorn PA
    J Neurol; 2006 Sep; 253(9):1143-6. PubMed ID: 16998652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: a randomized, blinded, crossover study.
    Shaygannejad V; Janghorbani M; Ashtari F; Zakeri H
    Neurol Res; 2012 Nov; 34(9):854-8. PubMed ID: 22979982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis. The Canadian MS Research Group.
    Can J Neurol Sci; 1987 Aug; 14(3):273-8. PubMed ID: 2889518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trial.
    Kronenberger B; Berg T; Herrmann E; Hinrichsen H; Gerlach T; Buggisch P; Spengler U; Goeser T; Nasser S; Wursthorn K; Pape GR; Hopf U; Zeuzem S
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):639-46. PubMed ID: 17625432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo.
    Krupp LB; Coyle PK; Doscher C; Miller A; Cross AH; Jandorf L; Halper J; Johnson B; Morgante L; Grimson R
    Neurology; 1995 Nov; 45(11):1956-61. PubMed ID: 7501140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of fatigue over 20 years after recovery from Guillain-Barré syndrome.
    Drory VE; Bronipolsky T; Bluvshtein V; Catz A; Korczyn AD
    J Neurol Sci; 2012 May; 316(1-2):72-5. PubMed ID: 22336700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological/-psychiatric deficits in immune-mediated neuropathies.
    Chan A; Gold R
    J Neurol; 2007 May; 254 Suppl 2():II93-5. PubMed ID: 17503141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial.
    Nourbakhsh B; Revirajan N; Waubant E
    Contemp Clin Trials; 2018 Jan; 64():67-76. PubMed ID: 29113955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group.
    Merkies IS; Schmitz PI; Samijn JP; van der Meché FG; van Doorn PA
    Neurology; 1999 Nov; 53(8):1648-54. PubMed ID: 10563607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, placebo-controlled trial of amantadine for the treatment of fatigue in patients with the post-polio syndrome.
    Stein DP; Dambrosia JM; Dalakas MC
    Ann N Y Acad Sci; 1995 May; 753():296-302. PubMed ID: 7611638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does amantadine have favourable effects on fatigue in Persian patients suffering from multiple sclerosis?
    Ashtari F; Fatehi F; Shaygannejad V; Chitsaz A
    Neurol Neurochir Pol; 2009; 43(5):428-32. PubMed ID: 20054744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon and amantadine in naive chronic hepatitis C: a double-blind, randomized, placebo-controlled trial.
    Helbling B; Stamenic I; Viani F; Gonvers JJ; Dufour JF; Reichen J; Cathomas G; Steuerwald M; Borovicka J; Sagmeister M; Renner EL;
    Hepatology; 2002 Feb; 35(2):447-54. PubMed ID: 11826422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amantadine therapy for fatigue in multiple sclerosis.
    Murray TJ
    Can J Neurol Sci; 1985 Aug; 12(3):251-4. PubMed ID: 3902184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.